Search research articles
Contact Us
Filters
Showing results (71-80 of 461) with videos related to
Page
of 47
Sort By:
Science Translational Medicine
|
March 31, 2012
Beyond PSA: the next generation of prostate cancer biomarkers
John R Prensner, Mark A Rubin, John T Wei, et al.
American Journal of Clinical Pathology
|
November 12, 2003
Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations
Lakshmi P Kunju, Mark A Rubin, Arul M Chinnaiyan, et al.
The Journal of Urology
|
March 26, 2002
Use of absorbable cyanoacrylate glue to repair an open cystotomy
Brian D Seifman, Mark A Rubin, Antoinette L Williams, et al.
Human Pathology
|
July 16, 2005
Intertubular growth in pure seminomas: associations with poor prognostic parameters
Tara-Jane Browne, Jerome P Richie, Timothy D Gilligan, et al.
Human Pathology
|
July 17, 2013
V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application
Kyung Park, Ya-Lin Chiu, Mark A Rubin, et al.
European Urology Focus
|
July 21, 2017
The Molecular Evolution of Castration-resistant Prostate Cancer
Yvonne Ceder, Anders Bjartell, Zoran Culig, et al.
BMC Genomics
|
April 19, 2015
Functional characterization of BC039389-GATM and KLK4-KRSP1 chimeric read-through transcripts which are up-regulated in renal cell cancer
Dorothee Pflueger, Christiane Mittmann, Silvia Dehler, et al.
Human Pathology
|
August 28, 2002
Inadequate formalin fixation decreases reliability of p27 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays
Angelo M De Marzo, Helen H Fedor, Wesely R Gage, et al.
The American Journal of Pathology
|
January 1, 2003
Dysregulation of the annexin family protein family is associated with prostate cancer progression
Wei Xin, Daniel R Rhodes, Collette Ingold, et al.
Molecular Cell
|
June 20, 2015
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Felix Y Feng, Johann S de Bono, Mark A Rubin, et al.
Page
of 47
Search research articles
Search
Showing results (71-80 of 461) with videos related to
Sort By:
Page
of 47
Science Translational Medicine
|
March 31, 2012
Beyond PSA: the next generation of prostate cancer biomarkers
John R Prensner, Mark A Rubin, John T Wei, et al.
American Journal of Clinical Pathology
|
November 12, 2003
Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations
Lakshmi P Kunju, Mark A Rubin, Arul M Chinnaiyan, et al.
The Journal of Urology
|
March 26, 2002
Use of absorbable cyanoacrylate glue to repair an open cystotomy
Brian D Seifman, Mark A Rubin, Antoinette L Williams, et al.
Human Pathology
|
July 16, 2005
Intertubular growth in pure seminomas: associations with poor prognostic parameters
Tara-Jane Browne, Jerome P Richie, Timothy D Gilligan, et al.
Human Pathology
|
July 17, 2013
V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application
Kyung Park, Ya-Lin Chiu, Mark A Rubin, et al.
European Urology Focus
|
July 21, 2017
The Molecular Evolution of Castration-resistant Prostate Cancer
Yvonne Ceder, Anders Bjartell, Zoran Culig, et al.
BMC Genomics
|
April 19, 2015
Functional characterization of BC039389-GATM and KLK4-KRSP1 chimeric read-through transcripts which are up-regulated in renal cell cancer
Dorothee Pflueger, Christiane Mittmann, Silvia Dehler, et al.
Human Pathology
|
August 28, 2002
Inadequate formalin fixation decreases reliability of p27 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays
Angelo M De Marzo, Helen H Fedor, Wesely R Gage, et al.
The American Journal of Pathology
|
January 1, 2003
Dysregulation of the annexin family protein family is associated with prostate cancer progression
Wei Xin, Daniel R Rhodes, Collette Ingold, et al.
Molecular Cell
|
June 20, 2015
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Felix Y Feng, Johann S de Bono, Mark A Rubin, et al.
Page
of 47